HF
VIVS

HRT Financial’s VivoSim Labs VIVS Stock Holding History

HRT Financial’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Buy
+18,319
New +$24.6K ﹤0.01% 3933
2025
Q4 		– Sell
-31,602
Closed -$92K – 4314
2025
Q3 		$92K Buy
+31,602
New +$74.9K ﹤0.01% 2539
2020
Q3 		– Sell
-54
Closed -$7K – 2464
2020
Q2 		$7K Buy
+54
New +$6.58K ﹤0.01% 1485
2015
Q3 		– Sell
-107
Closed -$96K – 202
2015
Q2 		$96K Buy
+107
New +$120K 0.05% 154

Other funds holding VIVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.81B AUM 32.31% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HRT Financial's VIVS Position: Q2 2026 in Review

HRT Financial opened a new position in VivoSim Labs (VIVS) in Q2 2026: 18,319 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #3933 among its holdings. This is a return to the name: HRT Financial previously reported a position in VIVS as recently as Q3 2025.

HRT Financial first reported a position in VIVS in Q2 2015 and has held it in 4 quarters since. The position peaked at $96K in Q2 2015. 26 funds tracked by Wall St. Rank hold VIVS as of Q2 2026.

  • HRT Financial held 18,319 shares of VivoSim Labs worth $19K as of Q2 2026.
  • VivoSim Labs was a new HRT Financial position in Q2 2026.
  • VivoSim Labs made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3933 holding.
  • HRT Financial first reported a position in VivoSim Labs in Q2 2015 and has held it in 4 quarters since.
  • HRT Financial's VivoSim Labs position peaked at $96K in Q2 2015.
  • 26 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.